{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:23:55Z","timestamp":1792265035742,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Korea Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["RS-2024-00331719"],"award-info":[{"award-number":["RS-2024-00331719"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Korea Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["21153MFDS601"],"award-info":[{"award-number":["21153MFDS601"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010418","name":"Institute for Information and Communications Technology Promotion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00509257"],"award-info":[{"award-number":["RS-2024-00509257"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.numecd.2026.104572","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:43:17Z","timestamp":1768894997000},"page":"104572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sodium glucose transporter 2 inhibitor exposure and the risk of congenital malformations: nationwide birth cohort study"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5631-4685","authenticated-orcid":false,"given":"Minseol","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9844-9145","authenticated-orcid":false,"given":"Miryoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3445-6607","authenticated-orcid":false,"given":"Hae Sun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2026.104572_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109050","article-title":"IDF diabetes atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by international association of diabetes in pregnancy study group's criteria","volume":"183","author":"Wang","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"10.1016\/j.numecd.2026.104572_bib2","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.2337\/dc06-0914","article-title":"HbA1c in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes","volume":"29","author":"Nielsen","year":"2006","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.numecd.2026.104572_bib3","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/dme.13923","article-title":"An Irish national diabetes in pregnancy audit: aiming for best outcomes for women with diabetes","volume":"37","author":"Egan","year":"2020","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.numecd.2026.104572_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9378(00)70217-1","article-title":"Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes","volume":"182","author":"Schaefer-Graf","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.numecd.2026.104572_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.diabres.2012.09.002","article-title":"Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment","volume":"98","author":"Falavigna","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.numecd.2026.104572_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.clinthera.2017.02.008","article-title":"Type 2 diabetes mellitus treatment patterns across Europe: a population-based multi-database study","volume":"39","author":"Overbeek","year":"2017","journal-title":"Clin Ther"},{"issue":"Suppl 1","key":"10.1016\/j.numecd.2026.104572_bib7","article-title":"Management of diabetes in pregnancy: standards of medical care in Diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2026.104572_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","article-title":"Effects of SGLT2 inhibitors on kidney and cardiovascular function","volume":"83","author":"Vallon","year":"2021","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"10.1016\/j.numecd.2026.104572_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCULATIONAHA.120.051685","article-title":"Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function","volume":"143","author":"Zannad","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104572_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108861","article-title":"Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure","volume":"270","author":"Armillotta","year":"2025","journal-title":"Pharmacol Therapeut"},{"issue":"2","key":"10.1016\/j.numecd.2026.104572_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy","volume":"184","author":"Cesta","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.numecd.2026.104572_bib13","first-page":"799","article-title":"Data resource profile: the national health information database of the national health insurance service in South Korea","volume":"46","author":"Cheol","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.numecd.2026.104572_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pds.3284","article-title":"Algorithms to estimate the beginning of pregnancy in administrative databases","volume":"22","author":"Margulis","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.numecd.2026.104572_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson comorbidity index: a critical review of clinimetric properties","volume":"91","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom"},{"issue":"5","key":"10.1016\/j.numecd.2026.104572_bib16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3182a603bb","article-title":"Development of a comorbidity index for use in obstetric patients","volume":"122","author":"Bateman","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.numecd.2026.104572_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116177","article-title":"Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: an ex vivo human placenta perfusion and in vitro study","volume":"171","author":"Kuoni","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.1016\/j.numecd.2026.104572_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/a-0958-2441","article-title":"Systematic review and meta-analysis of randomized controlled trials on the effect of SGLT2 inhibitor on blood leptin and adiponectin level in patients with type 2 diabetes","volume":"51","author":"Wu","year":"2019","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.numecd.2026.104572_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1095\/biolreprod.105.045120","article-title":"Leptin in pregnancy: an update","volume":"74","author":"Henson","year":"2006","journal-title":"Biol Reprod"},{"key":"10.1016\/j.numecd.2026.104572_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1215356","article-title":"Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence","volume":"14","author":"Muller","year":"2023","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.numecd.2026.104572_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/cpt.676","article-title":"Evaluation of the safety of drugs and biological products used during lactation: workshop summary","volume":"101","author":"Wang","year":"2017","journal-title":"Clin Pharmacol Ther"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:41:37Z","timestamp":1777592497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475326000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0939475326000347"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104572","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium glucose transporter 2 inhibitor exposure and the risk of congenital malformations: nationwide birth cohort study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"104572"}}